Members of his laboratory are developing several cutting-edge proteomics technologies for immunological applications, including multiplex planar-based autoantigen microarrays for studying lupus, multiple sclerosis, Rheumatoid Arthritis, and other diseases such as diabetes, sclerosing cholanitis, and inflammatory bowel disease; reverse phase protein lysate microarrays for studying blood cells; and